ADC Therapeutics targets $600M–$1B peak revenue potential for ZYNLONTA amid strategic refocus and cost cuts ADC Therapeutics targets $600M–$1B peak revenue potential for ZYNLONTA amid strategic refocus and cost cuts Post ContentadctRead More You might also be interested in reading Unity Software soars after Q4 beat, while Nebius tumbles. August 12, 2025 In Mainstream ← Previous post Next post →